Related Experiment Video
Updated: Aug 13, 2026

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
Expression of lectin-like oxidized LDL receptor-1 in smooth muscle cells after vascular injury
Hideyuki Eto1, Masaaki Miyata, Noriaki Kume
1Department of Cardiovascular, Respiratory and Metabolic Medicine, Graduate School of Medicine, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan.
Abstract:
Lectin-like oxidized LDL receptor-1 (LOX-1) is an oxidized LDL receptor, and its role in restenosis after angioplasty remains unknown. We used a balloon-injury model of rabbit aorta, and reverse transcription-polymerase chain reaction revealed that LOX-1 mRNA expression was modest in the non-injured aorta, reached a peak level 2 days after injury, and remained elevated until 24 weeks after injury. Immunohistochemistry and in situ hybridization showed that LOX-1 was not detected in the media of non-injured aorta but expressed in both medial and neointimal smooth muscle cells (SMC) at 2 and 24 weeks after injury. Low concentrations of ox-LDL (10 microg/mL) stimulated the cultured SMC proliferation, which was inhibited by antisense oligonucleotides of LOX-1 mRNA. Double immunofluorescence staining showed the colocalization of LOX-1 and proliferating cell nuclear antigen in human restenotic lesion. These results suggest that LOX-1 mediates ox-LDL-induced SMC proliferation and plays a role in neointimal formation after vascular injury.
Insights
Lectin-like oxidized LDL receptor-1 (LOX-1) drives smooth muscle cell proliferation and contributes to neointimal formation after vascular injury. This receptor plays a key role in restenosis following angioplasty.
Area of Science:
- Cardiovascular Biology
- Vascular Biology
- Molecular Medicine
Background:
- Lectin-like oxidized LDL receptor-1 (LOX-1) is an oxidized LDL receptor.
- Its specific role in restenosis after angioplasty is not fully understood.
Purpose of the Study:
- To investigate the role of LOX-1 in neointimal formation and smooth muscle cell proliferation following vascular injury.
Main Methods:
- Balloon-injury model in rabbit aorta.
- Reverse transcription-polymerase chain reaction (RT-PCR) for LOX-1 mRNA expression.
- Immunohistochemistry and in situ hybridization for LOX-1 protein localization.
- In vitro studies on cultured smooth muscle cells (SMC) with oxidized LDL (ox-LDL) and LOX-1 antisense oligonucleotides.
- Double immunofluorescence staining for LOX-1 and proliferating cell nuclear antigen (PCNA).
Main Results:
- LOX-1 mRNA expression peaked 2 days post-injury and remained elevated for 24 weeks.
- LOX-1 was expressed in medial and neointimal SMCs after injury, but not in non-injured aorta.
- Low concentrations of ox-LDL stimulated SMC proliferation, which was inhibited by LOX-1 antisense oligonucleotides.
- LOX-1 colocalized with PCNA in human restenotic lesions.
Conclusions:
- LOX-1 mediates ox-LDL-induced SMC proliferation.
- LOX-1 plays a significant role in neointimal formation after vascular injury.
- Targeting LOX-1 may be a therapeutic strategy for preventing restenosis.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction
Vascular Spasm
Inflammation

